The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...
Hosted on MSN1d
The city where the most people have tried injectable weight loss medications—and see the rest of the top 50The market for injectable weight loss medications has experienced rapid growth. Goldman Sachs Research predicts the global ...
With Alhemo (concizumab-mtci) from Novo Nordisk A/S, a third hemophilia drug in the past eight months has been approved by the U.S. FDA. The once-daily injectable prophylaxis is to prevent or reduce ...
Weight loss drugs like Ozempic and Wegovy have seemingly taken over this year, curbing users appetites by making them feel ...
The research team led by Dr. Moon-Hyeong Seo from the Natural Product Drug Development Center at the Korea Institute of ...
Popular dog arthritis medication Librela linked to pet illnesses, deaths, FDA says in urgent warning
Dangerous side effects from the injectable canine drug Librela — used to treat osteoarthritis joint pain — have been linked ...
The FDA delays Johnson & Johnson's SC amivantamab approval for NSCLC over facility inspection issues, unrelated to product ...
Approved in 2022 for type 2 diabetes and in 2023 for chronic weight management along with diet and exercise, tirzepatide is ...
FDA approves Hikma Pharmaceuticals' generic version of Victoza, a once-daily GLP-1 injection for Type 2 diabetes. Other drugmakers also entering the market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback